CDC Warns that A Brand of Eyedrops May Be Linked to Serious Infections and Death
Lever & Ecker, PLLC
February 2, 2023
On January 20, 2023, the Center for Disease Control (CDC) issued a statement urging consumers to discontinue the use of EzriCare Artificial Tears in light of the significant risk of eye infections and other issues posed by the use of the product. In particular, consumer use of EzriCare Artificial Tears has been linked to a bacteria called Pseudomonas aeruginosa, which is resistant to most antibiotics and can cause eye infections and other serious complications, including permanent vision loss and death.
The CDC has identified at least 50 individuals in multiple states, including New York, New Jersey, and Connecticut, who reported use of EzriCare Artificial Tears prior to being diagnosed with an eye infection.
On February 3, 2023, the product manufacturer, Global Pharma, issued a recall on EziriCare Artificial Tears, and has since asked distributors of the product to pull it from their shelves. The CDC has recommended that consumers of EziriCare Artificial Tears should immediately stop using the eye drops until further testing has been completed.
While this is a developing story, the manufacturers of EzriCare Artificial Tears may be liable for the damages caused to individuals who suffered injuries from using their product.
If you or someone you know suffered eye infections or other health complications after using EzriCare Artificial Tears, please contact the attorneys at Lever & Ecker, PLLC, to discuss what legal options are available and how we can help you and your loved ones seek justice. We at Lever & Ecker, PLLC would welcome the opportunity to help you.
Lever & Ecker, PLLC is a personal injury firm located in White Plains and the Bronx, NY. Our attorneys have represented clients in a wide variety of personal injury cases including automobile accidents, slip/trip and fall accidents, construction accidents, and nursing home negligence, among various others. Please contact us at (914) 288-9191 or email@example.com for more information.